Theranos Investor Conference Presentation Deck slide image

Theranos Investor Conference Presentation Deck

Hematology and Immunology: Assay Methodology CD3+T cells CD4+ T cells CD8+ T cells CD19+ B cells CD56+/CD16+ NK cells Two reaction tubes stained on-board Erythrocytes lysed and leukocytes fixed This technology has not been cleared or approved by the FDA and is not for sale in the United States. Samples are loaded into an imaging slide Images and cell properties analyzed using classification algorithms theran s 39
View entire presentation